Wesfarmers (ASX:WES) share price lower despite API takeover update

Wesfarmers has made a big step towards acquiring API…

| More on:
Three different hands against a blue backdrop signal thumbs up, indicating share price rise on the ASX market

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Wesfarmers is aiming to acquire Priceline pharmacy operator, API.
  • The company was given a boost today after the ACCC said it will not oppose the transaction
  • The regulator doesn't expect it to lessen competition

The Wesfarmers Ltd (ASX: WES) share price is falling on Friday despite being given some good news.

At the time of writing, the conglomerate's shares are down 1.5% to $52.56.

Wesfarmers share price lower despite acquisition update

The Wesfarmers share price is in the red this morning despite revealing that it has received confirmation from the Australian Competition and Consumer Commission (ACCC) that it will not oppose its proposed acquisition of Australian Pharmaceutical Industries Limited (ASX: API).

Wesfarmers notes that ACCC clearance was a condition precedent for the transaction. This brings the transaction a step closer to successfully completing around the end of the first quarter of the 2022 calendar year.

What did the ACCC say?

The ACCC advised that its review primarily focused on the markets for the retail sale of over-the-counter pharmaceutical and beauty and personal care products.

Positively for Wesfarmers, the regulator didn't see any issues with the transaction due to competition from the likes of Coles Group Ltd (ASX: COL) and Woolworths Group Ltd (ASX: WOW).

ACCC Commissioner Stephen Ridgeway explained: "Our investigation showed that there are many large and well-established retailers, including Chemist Warehouse, Woolworths and Coles, that will compete strongly with Wesfarmers after the acquisition in both the market for over-the-counter pharmaceutical products and the market for beauty & personal care products."

"We consider that API's competitors will continue to compete strongly with Wesfarmers after the acquisition," he added.

The ACCC also considered the impact that owning the Priceline Sister Club and 50% of Flybuys could have on competition. This includes whether the acquisition would reduce competition by incentivising and locking customers into shopping at Wesfarmers-aligned pharmacies and providing it with access to increased customer data.

Mr Ridgeway said: "Wesfarmers acquiring the Priceline Sister Club loyalty scheme will not have a lock-in effect on consumers in any market. We also consider the benefits obtained from the additional customer transaction data do not appear to be so strong as to result in a substantial lessening of competition from the acquisition. Customers generally do not only join one loyalty scheme, and major competitors to Wesfarmers after the acquisition will have, or could start, their own customer loyalty schemes."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns and has recommended COLESGROUP DEF SET and Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Mergers & Acquisitions

A man sits in a chair hunched over a laptop and covered head to toe in frozen icicles to represent Envirosuite's trading halt
Mergers & Acquisitions

APM share price placed on ice as $1.8 billion deal goes dud

It's all question marks and raised eyebrows for shareholders of this ASX company today.

Read more »

Young man sitting at a table in front of a row of pokie machines staring intently at a laptop. looking at the Crown Resorts share price
Mergers & Acquisitions

Could Star Entertainment shares be next in line to catch a takeover bid?

Star shares have been battered, but could a buyout be coming?

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Bank Shares

Own CBA shares? Here's the tech stock the banking giant just invested in

CBA has made an interesting investment. Here's what you need to know.

Read more »

Man pointing at a blue rising share price graph.
Mergers & Acquisitions

Guess which ASX 300 stock is rocketing 10% on a $985 million cash bid!

Investors are piling into the ASX 300 stock on the back of a $985 million cash takeover bid.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Mergers & Acquisitions

Guess which ASX blue-chip share is throwing $202 million at another acquisition

This Aussie healthcare company is growing its presence in Switzerland.

Read more »

A man stands with his arms crossed in an X shape.
Mergers & Acquisitions

Boral share price falls after rejecting Seven Group takeover

The offer 'undervalues' Boral according to its committee.

Read more »

Miner looking at a tablet.
Materials Shares

Mineral Resources share price marching higher on new lithium project acquisition

ASX 200 investors are bidding up the Mineral Resources share price on Monday.

Read more »

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Technology Shares

Appen shares plunges 17% after takeover collapse

Well that didn't take long...

Read more »